Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,155,774
+$118,538 QoQ
Shares Held
32,898
-0.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#257
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Providence Capital Advisors, LLC holds $29,086,080 across 11 Drug Manufacturers - General names. NVS ranks #1 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
This page
|
32,898 | $5,155,774 | |
| 2 | ABBV |
AbbVie Inc.
|
18,952 | $4,769,081 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
82,081 | $4,729,507 | |
| 4 | PFE |
Pfizer Inc
|
168,652 | $4,061,140 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,948 | $3,976,818 | |
| 6 | SNY |
Sanofi
|
85,773 | $3,659,076 | |
| 7 | JNJ |
Johnson & Johnson
|
7,395 | $1,878,108 | |
| 8 | LLY |
ELI LILLY & Co
|
602 | $722,056 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,155,774 | 32,898 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $5,037,236 | 32,977 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,423,145 | 32,082 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,972,105 | 30,974 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,645,910 | 30,129 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,265,137 | 29,289 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,814,205 | 28,920 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,325,573 | 28,913 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,782,843 | 35,533 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,396,867 | 35,117 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,463,674 | 34,304 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,606,557 | 35,407 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,553,444 | 35,214 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,192,032 | 34,696 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $3,094,277 | 34,108 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,592,701 | 34,110 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,824,316 | 33,412 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,002,191 | 22,817 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,835,295 | 20,982 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,647,785 | 20,149 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,668,962 | 18,292 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,469,999 | 17,197 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,588,784 | 16,825 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,313,965 | 15,110 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,277,085 | 14,622 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $1,215,642 | 14,744 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||